Not everyone needs to reach the highest doses
It is not listed in the FDA's Orange Book, and no Investigational New Drug (IND) application for BPC-157 has been publicly disclosed
Sarah Ro, director of the University of North Carolina Medical Groups weight management program, said expanded access could reduce long-term health costs while benefiting patients
The FDA label for bupropion notes that co-administration with CYP2B6 inhibitors (ticlopidine, clopidogrel) can raise bupropion AUC by up to 5.6-fold, but this warning applies only to drugs that share CYP pathways [3]
[DOI] [PubMed] [Google Scholar] 63.Montebugnoli L, Grelli I, Cervellati F, Misciali C, Raone B
In practice, KPV has not been reported to cause significant tanning or other melanocortin side effects at community doses